PRN only checks the format of manuscripts, and contacts the corresponding author to confirm his/her approval of submission.
VM, MB, LA, OH, TdL, IB, ØK, TG, GHH, OL and PS contributed with acquisition of data, interpretation of results, critical revision of the manuscript and approval of submission for publication.
The main responsibility of the DRA professional within a pharmaceutical company is to secure approval of drug submissions from Health Canada's Therapeutic Products Programme (TPP) and to ensure regulatory compliance of marketed and investigational drugs with the Food and Drug Act and Regulations and TPP Guidelines/Policies.
All authors gave final approval for submission of the manuscript.
JL and YSP produced a final draft and provided approval for submission of this manuscript.
They all gave their final approval for submission of this version.
Approval of the submission to the Journal – All coauthors.
All authors were responsible for final approval of manuscript submission.
All authors contributed to its revision and approval of final submission.
BG, GO and EM contributed to the literature search, provision of original data and final approval of the submission.
NZ conceived of the project, designed, supervised, and coordinated the entire studies, and is responsible for the final edition of the manuscript and approval of the submission.
